Delivery order for roche reagents for FY25. Option III: 01 OCT 2024 - 30 SEP 2025
Ended Awarded Last action
- Contract number
- W81K0224F0141
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $295,533
Award facts
- Opportunity
-
- Histology Automated H&E, IHC, and Special Staining System Pre-Solicitation · W81K0221Q0147 · Posted May 21, 2021
- Contract value 100% obligated
- $295,532.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$59,432 | |
| Funding Only Action | $354,965 | |
| Original award | $0 |
About this award
The Defense Health Agency (DHA) awarded a delivery order to Roche Diagnostics Corporation for the provision of Roche test reagents in Fiscal Year 2025. This delivery order, designated as Option III, covers the period from October 1, 2024, through September 30, 2025, with a ceiling value of $295,532.69 under a firm fixed-price contract type. The award was made on October 1, 2024, with performance taking place in Castleton, Indiana. No set-aside designation was applied to this contract award. This delivery order represents a continuation of DHA's ongoing relationship with Roche Diagnostics for laboratory reagents and diagnostic supplies that support military healthcare operations.
Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, is the prime contractor for this award. The company is a global leader in diagnostic solutions and has established a significant presence in the federal healthcare marketplace through numerous contracts with the DHA, Department of Veterans Affairs, and other federal healthcare agencies. This delivery order is a child contract, likely stemming from an existing indefinite delivery vehicle or General Services Administration schedule contract. The reagents and testing supplies provided under this award support critical diagnostic capabilities across the military healthcare system, including molecular testing, clinical chemistry, immunochemistry, and specialized diagnostic services essential to patient care and medical operations.
Quick answers
Who was awarded contract W81K0224F0141?
W81K0224F0141 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0224F0141 worth?
The government has obligated $295,533 on W81K0224F0141.
Which agency awarded contract W81K0224F0141?
Medical Command (Department of the Army) awarded W81K0224F0141, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0141 an order under another contract?
Yes. W81K0224F0141 is a delivery order under W81K0221D0007, an indefinite delivery contract.
Was contract W81K0224F0141 competed?
The extent of competition for W81K0224F0141 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award